Scenarios that move SYRE
Spyre Therapeutics, Inc. - Common Stock
Scenarios that move SYRE: 2 analyses, 1 positive, 1 negative.
- · Spyre Therapeutics prices $350 million public stock offering — ▼ · impact -70 · confidence high · horizon immediate
- · Oruka Therapeutics reports positive week 28 ORKA-001 trial data — ▲ · impact +30 · confidence low · horizon weeks